Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin degludec injection vs Tresiba in type 2 diabetes
CTR20220152Phase 3Completed
- Sponsor
- The United Laboratories International Holdings
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by The United Laboratories International Holdings. Started Jan 2022; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20220152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220152.